Latest Liquidity News

London City Equities Limited reports a robust 12% increase in its investment portfolio for the half year ending December 2024, driven by strong Fiducian Group performance and strategic share sales, enabling higher dividend payouts despite ongoing legal challenges.

Harris Technology Group Limited reported $3.6 million in sales and a positive operating cash flow in Q2 FY25, driven by strong performance in refurbished technology products as the company adjusts its inventory strategy.

Swift Networks reports steady cash flow and contract wins in mining and aged care, while unveiling a new feature to capitalize on upcoming aged care legislation.

Argosy Minerals Limited reported a net cash outflow in its December 2024 quarter, driven by exploration and evaluation expenses, ending with nearly $6 million in cash reserves.

SIV Capital Limited reported a negative operating cash flow for Q2 FY25 and remains suspended from ASX trading due to compliance issues, while actively exploring acquisition opportunities.

MEC Resources has moved to place remaining shortfall shares and options following its recent entitlement offer, signaling a continued push to strengthen its capital base.

Sagalio Energy Limited reported a net cash outflow of USD 79,000 in Q4 2024, ending the quarter with only USD 42,000 in cash and limited financing facilities. The company’s funding runway now stands at just over two quarters, raising questions about its near-term financial strategy.

Energy World Corporation Ltd. reports significant board changes and strategic committee formations as it navigates a quarter marked by operational cash outflows but maintains a solid cash reserve.

ENRG Elements Limited reported a $586,000 net cash outflow for the December quarter, offset by a $2.02 million equity raise, boosting its cash reserves to $2.52 million.

8VI Holdings Limited has confirmed its voluntary delisting from the ASX, reporting a challenging quarter marked by declining cash reserves and a strategic pivot towards preventive care that is yet to yield significant revenue.

Ten Sixty Four Limited has received a crucial US$10.5 million payment from Philsaga Mining Corporation, enabling it to settle outstanding related party debts and advance its Deed of Company Arrangement.

Alterity Therapeutics is poised to release topline data from its pivotal ATH434-201 Phase 2 trial in early-stage Multiple System Atrophy by February 2025, while managing a cash balance of A$4.54 million amid ongoing research expenses.